CDRH Inspection CPG Omits "Fatal Flaw" And Minor Nonconformities Clauses
This article was originally published in The Gray Sheet
Executive Summary
FDA's proposed policy of halting routine inspections when a serious nonconformance is identified has been removed from its final compliance program guide for medical device audits, released Feb. 8.